Copper Complex–based Imaging Agents to Diagnose Alzheimer's Disease (AD)

Science-Business eXchange
doi 10.1038/scibx.2013.1208
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Microbial-Generated Amyloids and Alzheimer's Disease (AD)

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2015English

3D Neuronal Culture Model of Alzheimer's Disease (AD)

Science-Business eXchange
2014English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Can the Retina Be Used to Diagnose and Plot the Progression of Alzheimer's Disease?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Recent Advances in Imaging Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2012English

Is Hyperhomocysteinemia an Alzheimer's Disease (AD) Risk Factor, an AD Marker, or Neither?

Trends in Pharmacological Sciences
ToxicologyPharmacology
2011English

From Pg to AD: Research Finds a Link Between Gum Disease and Alzheimer's

BDJ Team
2019English

Early-Onset Alzheimer's Disease: Nonamnestic Subtypes and Type 2 AD

Archives of Medical Research
Medicine
2012English

Rational Design of Early Premortem Alzheimer's Disease Diagnostic Agents

Biophysical Journal
Biophysics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy